Anna-Lena Spetz
Company: TIRmed
Job title: Chief Scientific Officer & founder
Seminars:
Development of a Topical Containing a Non-Coding Oligonucleotide 9:45 am
• Proof-of-concept study in canines with atopic dermatitis • Cutaneous CD11b+ cells that inhibit Th1/2/9 responses and promote Tregs are recruited by a non-coding oligonucleotide • Upregulation of immune-checkpoint proteins on cutaneous CD11b+ cellsRead more
day: Day Two